WMSA
LEGN icon

Weiss Multi-Strategy Advisers’s Legend Biotech LEGN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,106
Closed -$333K – 741
2021
Q2 		$333K Sell
8,106
-1,476
-15% -$50.2K 0.01% 592
2021
Q1 		$278K Buy
+9,582
New +$261K 0.01% 606

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LEGN Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Legend Biotech (LEGN) in Q3 2021, closing a stake of 8,106 shares — an estimated $333K sold.

Weiss Multi-Strategy Advisers first reported a position in LEGN in Q1 2021 and held it in 2 quarters. The position peaked at $333K in Q2 2021. 88 funds tracked by Wall St. Rank hold LEGN as of Q3 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Legend Biotech position as of Q3 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 8,106 Legend Biotech shares in Q3 2021, an estimated $333K.
  • Weiss Multi-Strategy Advisers first reported a position in Legend Biotech in Q1 2021 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Legend Biotech position peaked at $333K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.